Similar articles

• [Vaccines against Neisseria meningitidis].

  Ferrón L, Criado MT, Ferreirós CM. Ferrón L, et al. Enferm Infecc Microbiol Clin. 1992 May;10(5):296-301. Enferm Infecc Microbiol Clin. 1992. PMID: 1391002 Review. Spanish. No abstract available.
• The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.

  Jennings HJ. Jennings HJ. Contrib Microbiol Immunol. 1989;10:151-65. Contrib Microbiol Immunol. 1989. PMID: 2479499 Review. No abstract available.
• [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].

  Xu CH. Xu CH. Zhonghua Liu Xing Bing Xue Za Zhi. 1982 Dec;3(6):328-30. Zhonghua Liu Xing Bing Xue Za Zhi. 1982. PMID: 6821030 Chinese. No abstract available.
• [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].

  Wu C. Wu C. Zhonghua Liu Xing Bing Xue Za Zhi. 1985 Dec;6(6):344-6. Zhonghua Liu Xing Bing Xue Za Zhi. 1985. PMID: 3938683 Chinese. No abstract available.
• Right age for Meningococcal vaccine.

  John TJ. John TJ. Indian Pediatr. 1998 Jul;35(7):669-70. Indian Pediatr. 1998. PMID: 10216680 No abstract available.